Rosmarinic acid
Internal ID | 3406af2c-ffcf-4b7c-84dc-cf5b7bec9219 |
Taxonomy | Phenylpropanoids and polyketides > Cinnamic acids and derivatives > Hydroxycinnamic acids and derivatives > Coumaric acids and derivatives |
IUPAC Name | (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid |
SMILES (Canonical) | C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O |
SMILES (Isomeric) | C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)/C=C/C2=CC(=C(C=C2)O)O)O)O |
InChI | InChI=1S/C18H16O8/c19-12-4-1-10(7-14(12)21)3-6-17(23)26-16(18(24)25)9-11-2-5-13(20)15(22)8-11/h1-8,16,19-22H,9H2,(H,24,25)/b6-3+/t16-/m1/s1 |
InChI Key | DOUMFZQKYFQNTF-WUTVXBCWSA-N |
Popularity | 3,695 references in papers |
Molecular Formula | C18H16O8 |
Molecular Weight | 360.30 g/mol |
Exact Mass | 360.08451746 g/mol |
Topological Polar Surface Area (TPSA) | 145.00 Ų |
XlogP | 2.40 |
Atomic LogP (AlogP) | 1.76 |
H-Bond Acceptor | 7 |
H-Bond Donor | 5 |
Rotatable Bonds | 6 |
20283-92-5 |
Rosemary acid |
Labiatenic acid |
Rosmarinicacid |
Labiatic acid |
(R)-rosmarinic acid |
trans-Rosmarinic acid |
Rosemaric acid |
Rosmarinic acid racemate |
Rosmarinate |
There are more than 10 synonyms. If you wish to see them all click here. |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.8756 | 87.56% |
Caco-2 | - | 0.9373 | 93.73% |
Blood Brain Barrier | - | 0.5500 | 55.00% |
Human oral bioavailability | - | 0.7000 | 70.00% |
Subcellular localzation | Mitochondria | 0.8306 | 83.06% |
OATP2B1 inhibitior | - | 0.5749 | 57.49% |
OATP1B1 inhibitior | + | 0.9413 | 94.13% |
OATP1B3 inhibitior | + | 0.9479 | 94.79% |
MATE1 inhibitior | + | 0.5200 | 52.00% |
OCT2 inhibitior | - | 0.8250 | 82.50% |
BSEP inhibitior | + | 0.6882 | 68.82% |
P-glycoprotein inhibitior | - | 0.8529 | 85.29% |
P-glycoprotein substrate | - | 0.9340 | 93.40% |
CYP3A4 substrate | - | 0.5802 | 58.02% |
CYP2C9 substrate | - | 0.5979 | 59.79% |
CYP2D6 substrate | - | 0.8612 | 86.12% |
CYP3A4 inhibition | - | 0.8309 | 83.09% |
CYP2C9 inhibition | - | 0.8754 | 87.54% |
CYP2C19 inhibition | - | 0.9026 | 90.26% |
CYP2D6 inhibition | - | 0.9231 | 92.31% |
CYP1A2 inhibition | - | 0.6279 | 62.79% |
CYP2C8 inhibition | + | 0.5112 | 51.12% |
CYP inhibitory promiscuity | - | 0.8300 | 83.00% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 0.8141 | 81.41% |
Carcinogenicity (trinary) | Non-required | 0.6152 | 61.52% |
Eye corrosion | - | 0.9895 | 98.95% |
Eye irritation | + | 0.5264 | 52.64% |
Skin irritation | - | 0.7211 | 72.11% |
Skin corrosion | - | 0.9416 | 94.16% |
Ames mutagenesis | - | 0.7200 | 72.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.4806 | 48.06% |
Micronuclear | + | 0.7159 | 71.59% |
Hepatotoxicity | - | 0.6250 | 62.50% |
skin sensitisation | - | 0.5655 | 56.55% |
Respiratory toxicity | + | 0.5556 | 55.56% |
Reproductive toxicity | + | 0.6556 | 65.56% |
Mitochondrial toxicity | + | 0.5625 | 56.25% |
Nephrotoxicity | - | 0.8974 | 89.74% |
Acute Oral Toxicity (c) | III | 0.7720 | 77.20% |
Estrogen receptor binding | + | 0.8228 | 82.28% |
Androgen receptor binding | + | 0.8585 | 85.85% |
Thyroid receptor binding | + | 0.5265 | 52.65% |
Glucocorticoid receptor binding | + | 0.6399 | 63.99% |
Aromatase binding | - | 0.5927 | 59.27% |
PPAR gamma | + | 0.5798 | 57.98% |
Honey bee toxicity | - | 0.7466 | 74.66% |
Biodegradation | - | 0.8750 | 87.50% |
Crustacea aquatic toxicity | - | 0.5900 | 59.00% |
Fish aquatic toxicity | + | 0.9952 | 99.52% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL1900 | P15121 | Aldose reductase |
3910 nM |
IC50 |
PMID: 20071057
|
CHEMBL1293236 | P46063 | ATP-dependent DNA helicase Q1 |
3548.1 nM |
Potency |
via CMAUP
|
CHEMBL1293237 | P54132 | Bloom syndrome protein |
22387.2 nM |
Potency |
via CMAUP
|
CHEMBL2392 | P06746 | DNA polymerase beta |
223.9 nM 223.9 nM |
Potency Potency |
via CMAUP
via Super-PRED |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase |
631 nM 631 nM |
Potency Potency |
via CMAUP
via Super-PRED |
CHEMBL4159 | Q99714 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
25.1 nM |
Potency |
via Super-PRED
|
CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 |
2025.72 nM |
IC50 |
via CMAUP
|
CHEMBL1293226 | B2RXH2 | Lysine-specific demethylase 4D-like |
14125.4 nM |
Potency |
via CMAUP
|
CHEMBL2608 | P10253 | Lysosomal alpha-glucosidase |
2511.9 nM |
Potency |
via CMAUP
|
CHEMBL332 | P03956 | Matrix metalloproteinase-1 |
5600 nM |
IC50 |
PMID: 23353736
|
CHEMBL1293224 | P10636 | Microtubule-associated protein tau |
12589.3 nM 14125.4 nM 17782.8 nM |
Potency Potency Potency |
via CMAUP
via CMAUP via CMAUP |
CHEMBL4977 | P05412 | Proto-oncogene c-JUN |
16200 nM |
IC50 |
PMID: 24491635
|
CHEMBL1075189 | P14618 | Pyruvate kinase isozymes M1/M2 |
1000 nM 1000 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL1947 | P10828 | Thyroid hormone receptor beta-1 |
25118.9 nM 44668.4 nM |
Potency Potency |
via CMAUP
via CMAUP |
CHEMBL3194 | P02766 | Transthyretin |
8600 nM |
EC50 |
PMID: 25314129
|
CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN |
1300 nM 3600 nM 17000 nM 36000 nM 63000 nM 74000 nM |
IC50 IC50 IC50 IC50 IC50 IC50 |
PMID: 17315853
PMID: 17315853 PMID: 17315853 PMID: 17315853 PMID: 17315853 PMID: 17315853 |
CHEMBL258 | P06239 | Tyrosine-protein kinase LCK |
24000 nM 55000 nM |
IC50 IC50 |
PMID: 14505648
PMID: 19427202 |
CHEMBL267 | P12931 | Tyrosine-protein kinase SRC |
26000 nM |
IC50 |
PMID: 19427202
|
CHEMBL1075138 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 |
223.9 nM 223.9 nM 891.3 nM |
Potency Potency Potency |
via CMAUP
via Super-PRED via Super-PRED |
CHEMBL1293227 | O75604 | Ubiquitin carboxyl-terminal hydrolase 2 |
25118.9 nM |
Potency |
via CMAUP
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL1951 | P21397 | Monoamine oxidase A | 98.69% | 91.49% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 93.94% | 86.33% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 93.33% | 96.00% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 93.20% | 94.45% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 93.01% | 99.17% |
CHEMBL3194 | P02766 | Transthyretin | 92.66% | 90.71% |
CHEMBL4040 | P28482 | MAP kinase ERK2 | 92.41% | 83.82% |
CHEMBL2581 | P07339 | Cathepsin D | 91.23% | 98.95% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 88.96% | 95.56% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 88.95% | 96.09% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 88.66% | 90.17% |
CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 88.08% | 99.15% |
CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 87.53% | 95.50% |
CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 87.43% | 91.71% |
CHEMBL1255126 | O15151 | Protein Mdm4 | 81.75% | 90.20% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
PubChem | 5281792 |
NPASS | NPC61 |
ChEMBL | CHEMBL324842 |
LOTUS | LTS0207820 |
wikiData | Q50380051 |